“…Many studies reveal a wide spectrum of systemic and ocular conditions related to PAMM, primarily among patients with cardiovascular pathology. PAMM has been shown in patients with hypertension, sickle-cell disease, 13 after mitral valve implantation, 14 Purtscher's retinopathy, 15 after filler injections, 16 in occlusive retinal vasculitis, and other conditions which compromise the blood clotting system, including antiphospholipid syndrome, 17 in giant cell arteritis, 18 and COVID-19. 19 On the other hand, several cases describe PAMM lesions in individuals with an unremarkable medical history.…”